Alzheimer Disease

Disease State Hub

Podcasts

Podcast

Podcast

Diabetes Modifies the Effect of Alzheimer Disease-Related Dementia Mortality Among Black Americans

03/14/2024

Sri Banerjee, MD, PhD, MPH, MAS

In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, discusses the impact of diabetes on Alzheimer disease-related dementia mortality among Black Americans, including the burden and pathophysiology of...

03/14/2024

NUTRITION411: THE PODCAST, EP. 30

Controversies in the Impact of Diet on Alzheimer Disease Prevention, Management

12/22/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the key arguments and controversies surrounding specific diets in relation to Alzheimer disease prevention and management,...

12/22/2023

NUTRITION411: THE PODCAST, EP. 31

Nutrition Strategies for Improved Cognitive Function in Patients With Alzheimer Disease

11/16/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the practical and actionable nutrition strategies that dietitians can recommend to individuals managing Alzheimer disease...

11/16/2023

NUTRITION411: THE PODCAST, EP. 31

Nutrition Strategies for Improved Cognitive Function in Patients With Alzheimer Disease

11/16/2023

Lisa Jones, MA, RDN, LDN, FAND

11/16/2023

NUTRITION411: THE PODCAST, EP. 31

Nutrition Strategies for Improved Cognitive Function in Patients With Alzheimer Disease

11/16/2023

Lisa Jones, MA, RDN, LDN, FAND

11/16/2023

NUTRITION411: THE PODCAST, EP. 29

Practical Dietary Recommendations for Patients at Risk, Diagnosed With Alzheimer Disease

10/30/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones interviews Amylee Amos, PhD, RDN, IFMCP, about how dietitians can effectively translate the latest research on diet and Alzheimer disease into practical dietary...

10/30/2023

Nutrition411: The Podcast, Ep. 28

The Impact of Dietary Choices on Alzheimer Disease Prevention

10/23/2023

Lisa Jones, MA, RDN, LDN, FAND

In this podcast episode, Lisa Jones interviews Amylee Amos, PhD, RDN, IFMCP, about research that suggests a potential link between dietary choices and the development or prevention of Alzheimer disease and...

10/23/2023

Alzheimer Disease

The Association of Flavonols on Alzheimer Dementia Risk

05/19/2022

In this podcast, Thomas Holland, MD, from Rush University, answers our questions about his team's latest research on the effect of flavonols on the risk for Alzheimer dementia, as well as his other research...

05/19/2022

Geriatrics

ANA Investigates Biomarkers for Alzheimer Disease

08/19/2020

David Holtzman, MD, talks about the established biomarkers for Alzheimer disease, potential biomarkers being investigated, and how long it may take for these biomarker tests to make it to the bedside.

08/19/2020

Alzheimer Disease

Erin Sundermann, PhD, on Redefining the Norms and Cut Points for Diagnosing MCI Among Men vs Women

01/21/2020

In this podcast, Erin Sundermann, PhD, discusses her research on sex-specific norms and cut points for verbal memory tests and how redefining the criteria for men vs women may improve diagnostic accuracy of...

01/21/2020

For more on the etiology of Alzheimer disease content, visit our Clinical Update page

The most common type of dementia, Alzheimer disease is a progressive disease that generally begins with mild memory loss and involves parts of the brain that control thought, memory, and language.

For more Alzheimer Disease content, visit the Clinical Insights page

Brain changes may begin 10+ years before symptoms appear. These changes include buildup of proteins that form amyloid plaques and tau tangles. This causes healthy neurons to stop functioning, lose connections with other neurons, and die.

For more neurology content, visit the Resource Center

occupational therapist, neurologist, geriatrician, psychiatrist, primary care physicians, geropsychologist

For more dementia content, visit the Disease State Hub

Memory loss that disrupts daily life
Difficulty completing familiar tasks at home, at work, or at leisure
Worsening judgment
Misplacing items & failure to retrace steps
Changes in mood, personality, or behavior

For more imaging content, visit the Resource Center

There is no single test to determine AD, but testing options include: computed tomography scan, magnetic resonance imaging, positron emission tomography scan, cerebrospinal fluid analysis, neurological examination

For more neurological diseases content, visit the Disease State Hub

Examples of cognitive, functional, and behavioral tests include: Ascertain Dementia 8, Activities Questionnaire, Mini-Cog Mini-Mental State Examination, Montreal Cognitive Assessment, Neuropsychiatric Inventory Questionnaire

For more traumatic brain injury content, visit the Resource Center

Age
Family history
Genetics
Mild cognitive impairment
Modifiable risk factors, like obesity, high cholesterol, poorly controlled type 2 diabetes

For more polls and quizzes, visit the interactive features page

An estimated 6.7 million Americans aged 65 years or older are living with AD (73% are aged 75 years or older)

For more patient education content, visit the Resource Center

By 2025, the number of people aged 65 or older with AD is projected to reach 7.2 million — a 7% increase from 2023.

March 2024

Current Issue

March 2024

Volume 64

Issue 3

Sources

CDC.gov
2023 Alzheimer's Facts and Figures